Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion type Assertion NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_head.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion description "[The proliferation index assessed by using Ki-67 (MIB1) was 5% in the low-grade B-cell lymphoma, 80% in the plasmablastic myeloma, 90-95% in three cases of diffuse large B-cell lymphoma, and ranged from 90 to >99% in most Burkitt and atypical Burkitt neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_provenance.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion evidence source_evidence_literature NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_provenance.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion SIO_000772 16258503 NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_provenance.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion wasDerivedFrom befree-20140225 NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_provenance.
- NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_assertion wasGeneratedBy ECO_0000203 NP660322.RAvpPKZ8uVk5MGxkMXIIfMkm0PVzbyOX6QC1Dk9hEbtMI130_provenance.